Literature DB >> 18075258

The potential role of cyclin-dependent kinase 5 in focal cortical dysplasia.

Arjune Sen1, Maria Thom, Margareta Nikolić, Sanjay M Sisodiya.   

Abstract

Focal cortical dysplasia (FCD) is the most common malformation of cortical development found in epilepsy surgical series. Characterised by cortical mislamination, dysplastic neurons and, in a subgroup of cases, balloon cells, FCD is potently epileptogenic. Despite decades of study, the underlying aetiology of FCD remains uncertain and research has been hampered by the lack of a good animal model in which to simulate the condition. In this article we review some of the potential molecular mechanisms that might underpin human FCD. In particular we examine the potential role of cyclin-dependent kinase 5 and its principal activator p35 in FCD and estimate the contribution that deregulation of cyclin-dependent kinase 5 might make to the pathogenesis of this condition. Copyright (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18075258     DOI: 10.1159/000109855

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  8 in total

1.  Epilepsy: the new order-classifying focal cortical dysplasias.

Authors:  Sanjay Sisodiya
Journal:  Nat Rev Neurol       Date:  2011-03       Impact factor: 42.937

2.  Cognition in Epilepsy: ΔFosB Takes Center Stage (and May Star in the Prologue).

Authors:  Christina Gross
Journal:  Epilepsy Curr       Date:  2018 Sep-Oct       Impact factor: 7.500

Review 3.  The Pak1 kinase: an important regulator of neuronal morphology and function in the developing forebrain.

Authors:  Margareta Nikolić
Journal:  Mol Neurobiol       Date:  2008-07-22       Impact factor: 5.590

4.  Neurofibrillary tangle pathology and Braak staging in chronic epilepsy in relation to traumatic brain injury and hippocampal sclerosis: a post-mortem study.

Authors:  Maria Thom; Joan Y W Liu; Pam Thompson; Rahul Phadke; Marta Narkiewicz; Lillian Martinian; Derek Marsdon; Matthias Koepp; Luis Caboclo; Claudia B Catarino; Sanjay M Sisodiya
Journal:  Brain       Date:  2011-09-08       Impact factor: 13.501

Review 5.  Cognition and dementia in older patients with epilepsy.

Authors:  Arjune Sen; Valentina Capelli; Masud Husain
Journal:  Brain       Date:  2018-06-01       Impact factor: 13.501

Review 6.  Tauopathy and Epilepsy Comorbidities and Underlying Mechanisms.

Authors:  Kaylin Hwang; Rahil N Vaknalli; Kwaku Addo-Osafo; Mariane Vicente; Keith Vossel
Journal:  Front Aging Neurosci       Date:  2022-07-18       Impact factor: 5.702

7.  Application Value of Serum Metabolic Markers for Cognitive Prediction in Elderly Epilepsy.

Authors:  Hong Wei; Dandan Liu; Leiyu Geng; Yun Liu; Huiqin Wang; Fuling Yan
Journal:  Neuropsychiatr Dis Treat       Date:  2022-09-22       Impact factor: 2.989

8.  An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study.

Authors:  Arjune Sen; Mary Akinola; Xin You Tai; Mkael Symmonds; Gabriel Davis Jones; Sergio Mura; Joanne Galloway; Angela Hallam; Jane Y C Chan; Ivan Koychev; Chris Butler; John Geddes; Rohan Van Der Putt; Sian Thompson; Sanjay G Manohar; Eleni Frangou; Sharon Love; Rupert McShane; Masud Husain
Journal:  Trials       Date:  2021-07-31       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.